In this way, increased IDO1 activity helps downregulate several inflammatory diseases (20, 21), but on the other hand, it is also associated with neurologic disorders (22, 23), and in cancer cells or in host dendritic cells is associated with suppression of effector T-cell responses toward tumors (24, 25). The gene discussed is IDO1; the disease is cancer.